Objective: As 80% of intrauterine bone mineralization takes place during the last trimester of pregnancy, preterm infants should be supplemented postnatally with optimal doses of calcium, phosphate and vitamin D. Calcium and phosphate excretion in the urine may be used to monitor individual mineral requirements, but are sometimes difficult to interpret. The objective of this study was to assess the value of quantitative ultrasound (QUS) for the analysis of bone status in neonates.
Introduction
As 80% of bone mineralization in neonates occurs throughout the last trimester, it is not surprising that 39% of all neonates, born prematurly with a birth weight of less than 1500 g, suffer from osteopenia. 1 Because optimal postnatal nutritional supplementation may modify the degree of osteopenia, the clinical management would profit from a non-invasive and easily applicable method that is well tolerated even by extremely immature preterm infants and capable of providing quantitative information on bone mineral status. However, no generally accepted method is yet available for this purpose, especially as most techniques used for bone-density measurement in adults require ionizing radiation. Currently used methods for diagnosis of osteopenia in preterm infants are based on either serum values for calcium, phosphate and alkaline phosphatase (AP), or in some countries, on excretion of calcium and phosphate in the urine. Although the first method is invasive and adds to the constant iatrogenic blood loss in very-low-birth-weight infants, the second is non-invasive but much less reproducible even if results are corrected for urine concentration. 2, 3 In addition, both methods reflect bone mineral turnover that does not necessarily correlate with bone mineral density or mechanical strength. Although conventional X-rays are not sensitive enough to guide calcium and phosphate supplementation, dual-energy X-ray absorptiometry (DXA) is a recognized method to assess the skeletal status in the neonate. 4 But again, this technique is subject to several limitations. Apart from limited availability, need for neonatal transport, and concerns on the cumulative radiation dosage associated with repeated measurements, the variables provided by DXA (bone mineral content and areal bone mineral density) are substantially confounded by the changes in size and shape of the skeleton as well as in the amount of soft tissue occurring during the rapid growth of neonates.
In contrast, quantitative ultrasound (QUS) parameters were shown to depend on bone density, bone mechanical properties 5 and trabecular bone microstructure. 6 Recent studies have suggested that QUS parameters are also associated with other factors of bone strength, such as the geometry and porosity of cortical bone. 7 Both retrospective and prospective clinical studies have shown that QUS has similar abilities of predicting fracture at the proximal femur and spine in adults as DXA. 8 Although QUS is now widely used in adults and represents a relatively established method for evaluating bone mineral status in the context of diagnosing osteoporosis, QUS has only been employed in mostly small study samples of newborn infants and children. [9] [10] [11] [12] [13] [14] [15] [16] [17] However, none of these studies provide longitudinal data in regular intervals on QUS measurements in preterm infants simultaneously accounting for growth changes and increase of soft tissue. Therefore, we initiated a trial for the evaluation of QUS following both preterm and term infants in predefined intervals until the age of 17 months. By using a standardized measurement technique, we could minimize the effect of soft tissue growth and thus assess factors influencing early bone development.
The objective of this study was to evaluate the usefulness of QUS to monitor mineral supplementation in a large number of neonates comprising the whole spectrum of term and preterm infants. Specific objectives were to correlate QUS measurements in newborns with their gestational age and birth weight, follow-up bone development by QUS after birth and correlate QUS measurements with laboratory measures of bone metabolism, nutritional supplies and risk factors of osteopenia of prematurity.
Methods

QUS measurement
Ultrasound transmission velocity (m s À1 ) was measured using the Osteoson KIV (Minhorst, Meudt, Germany). The device has two probes of 10 mm diameter, one transmitting broadband ultrasound of 0.1 to 0.6 MHz, the other serving as receiver. These probes are positioned on a caliper that allows the attached computer to automatically calculate the exact distance between the two probes.
Before each measurement, the device was calibrated against air to give a velocity of 346 m s À1 . In each neonate, separate measurements were done at four different locations on one side of the patient's body that was randomly chosen before the first measurement. Measurement locations were the middle of the diaphysis of the long bones (humerus, radius/ulna combined, femur and tibia) because they calcify early in fetal development and their cylindrical shape and homogeneous bone density allows repositioning. For each of the four locations, 50 measurements were done within 1 to 2 min without change of position. Of these 50 measurements, the median of the 10 fastest values was calculated to include only those travelling through bone. Subsequently, the mean of all four medians from all four measurement locations was determined and used for further analysis.
In the measurement of neonates, fixed probe distances of 20 or 35 mm were used according to their size. The remaining distance between the probes and the skin of the neonate was filled with a precursor with a velocity identical to soft tissue in neonates (1560 m s À1 ) ( Figure 1 ). This velocity was calculated as the mean of 55 measurements of soft tissue conducted at the upper leg in 16 infants from 604 to 3060 g (1624 ± 559 g). By this calculation model, we selected values most likely representing bone, as ultrasound waves propagate fastest in dense tissue. The decision for this measuring method was based on experiments using isolated bones, where we observed a decrease of transmission velocity by 61% when the surrounding soft tissue, simulated by a gel layer, was increased from 5 to 20 mm. This increase in soft tissue is one of the most pronounced effects of body growth in neonates. Therefore, we limited this effect of soft tissue growth by maintaining the amount of surrounding tissue at a fixed valueFdepending on the size of the infantFat 20 or 35 mm. Consequently, values for 20 and 35 mm distances are not comparable.
Patients
After receiving informed consent from the parents, 602 measurements were performed on 172 newborn infants hospitalized in three independent level three neonatal care units and one healthy baby nursery at the Ludwig-Maximilian-University and the Technical University of Munich (Table 1) , if parents gave informed consent and study personnel was available. Neonates had a gestational age between 24 and 42 weeks (mean ± s.d: 33.8 ± 5.0) and a birth weight between 405 and 5130 g (2132±1091 g); 40 neonates (23%) were small-for-gestational-age (birth weight p10th percentile) (SGA). Measurements during the first week of life were available in 114 neonates, whereas 58 measurements were started after the first week.
Neonates were fed with a combined parenteral and oral regimen starting immediately after birth. Parenteral protein and fat in 10% glucose were increased within 5 days from 1 g kg À1 per day up to 2.5 and 3.5 g kg À1 per day, respectively. Adjustments for glucose, electrolytes and vitamins were made according to the infants' needs and international guidelines. As oral nutrition, preferably breast milk was fed enriched with 400 to 800 I. Measurements of QUS were repeated in 7-day intervals for the initial 55 infants and in and 14-day intervals thereafter. On the day of these follow-up measurements, the neonates' weights ranged from 600 to 7480 g (2078±979 g) and their postconceptional maturity, calculated as gestational plus postnatal age, from 25 to 68 weeks (34.5±5.2) ( Table 3 ). Infants were followed until their discharge home. Preterm infants with a birth weight below 1500 g were followed until up to 17 months of postconceptional age. The median time of observation between the first and last measurement was 5.8 weeks (1 to 45) and the mean number of examinations 3 per neonate (1 to 13) ( Table 4 ). To determine day-to-day reproducibility of the ultrasound Osteoson KIV, QUS was measured on two consecutive days in five neonates chosen at random from the collective described above with a median age of 29 weeks (27.3 to 35.1).
Detailed information on amount and composition of calcium, phosphate and vitamin D supplementation of the infants, as well as calcium and phosphate concentrations in serum and urine and AP in serum were acquired from the patients' charts. All clinical chemistry assays were conducted with the Integra 800 (Roche Diagnostics, Basel, Switzerland). The laboratory measurements were conducted at regular intervals according to clinical routine of the individual unites, but were not a mandatory part of the study protocol.
Statistical analysis
Cases with missing clinical or laboratory data and QUS measurements under treatment with diuretics (n ¼ 21) were excluded from the analysis concerned. For the correlation of QUS with laboratory or clinical risk factors for reduced bone mineralization, change of QUS per week was calculated (alteration of QUS over time (DQUS)), to analyze relative QUS changes independent of absolute postconceptional age and weight. All data were tested for normal distribution. Pearson and Spearman correlation coefficients were calculated for normally distributed and not normally distributed data, respectively. To compare categorical variables, the w 2 -test was employed. The two-tailed t-test was used to calculate the differences of the mean of independent samples that had continuous variables. In summary, 10 variables were analyzed for their influence on QUS values. Cox's regression analysis was used for multivariate analyses, to disclose the significant factors from univariate analysis that determine bone quality. The variables were entered forward stepwise. P values <0.05 were considered to be significant. All calculations were done with the computer software 'Statistical Package for the Social Sciences 12.0' (SPSS, Chicago, IL, USA).
Results
QUS measured in the first week of life
In 114 neonates, QUS measurements were performed within the first week of life. These values are as close as possible to intrauterine bone mineralization and those least altered by postnatal influence of nutrition or illness. Gestational age of these neonates ranged from 24 to 42 weeks (mean±s.d: 35.9±4.5, interquartile range 32 to 40 wks) and weight from 600 to 5010 g (2353 ± 1048 g, interquartile range 1521 to 3163 g) ( Table 2 ). There was a highly significant positive correlation between QUS and gestational age (r ¼ 0.53; P<0.001 both 20 and 35 mm) as well as birth weight (r ¼ 0.59 for 20 mm and r ¼ 0.51 for 35 mm; both P<0.001). QUS values measured with a probe distance of 20 mm were higher compared with those found with a probe distance of 35 mm.
For both SGA and appropriate-for-gestational-age (AGA) infants, QUS increased with gestational age and birth weight (P ¼ 0.001). (Figure 2 ), but not when correlated to birth weight (P ¼ 0.54). Repeated day-to-day measurements showed a 0.62% variation coefficient for QUS. Twelve infants were large for gestational age (980 to 5130 g; 26 to 42 weeks). QUS values were comparable to AGA infants of the same age and birth weight.
Follow-up measurements of QUS
The effect of postnatal changes on bone mineral density was examined by 602 follow-up measurements in 172 neonates between 25 and 68 postconceptional weeks (mean ± s.d: 34.5 ± 5.2) ( Table 3) . QUS values ranged from 1621 to 1832 (1710 ± 15 m s À1 ). Both for 20 mm probe distance (r ¼ 0.197; P ¼ 0.001) and for 35 mm probe distance (r ¼ 0.129; P ¼ 0.037), there was a significant correlation of QUS with increasing postconceptional age. Additionally, QUS during follow-up correlated highly significant with the weight on the day of measurement (r ¼ 0.377 for 20 mm and r ¼ 0.363 for 35 mm; both P ¼ 0.001). When we compared bone quality at the age of 40 In 60 newborns, repeated follow-up examinations (X3) were available. In all 32% of these neonates were small for gestational age. We observed an initial decrease of QUS during the first weeks of life followed by an increase. QUS changes correlated significantly with the infants' week of life at measurement (P ¼ 0.026 for 20 mm and 0.024 for 35 mm). QUS changes depended also on the maturity of the infants. Less mature infants showed a longer and more distinct decrease of QUS (Figure 3) . Furthermore, in preterm infants QUS development from week 1 to 3 of life correlated positively with QUS velocity at term (P ¼ 0.035).
Correlation of QUS with laboratory parameters and risk factors
In all 172 patients, calcium and phosphate excretion in the urine was available. Calcium concentration in urine was found to be 0.1 to 13.5 mmol l À1 (median 1.4 mmol l À1 ) and phosphate concentration in urine between 0.0 and 37.9 mmol l À1 (median 3.3 mmol l À1 ). There was no correlation of alteration of QUS over time (DQUS) with calcium concentration in urine (P ¼ 0.47) or phosphate concentration in urine (P ¼ 0.995). Calcium concentration in serum was found to be 1.26 to 2.9 mmol l À1 (median 2.4 mmol l À1 ), and phosphate concentration in serum between 0.91 and 8.23 mmol l À1 (median 2.05 mmol l
À1
). As expected, calcium concentration in serum and phosphate concentration in serum were not related to DQUS. (median 462 U l À1 ) was compared with 167 QUS measurements. In our patient group, AP was neither related to calcium concentration in urine (P ¼ 0.84) nor to calcium concentration in serum (P ¼ 0.28) or phosphate concentration in serum (P ¼ 0.68). However, there was a highly significant inverse correlation of AP with phosphate concentration in urine (P ¼ 0.001). Also, QUS values for both probe distances correlated inversely with AP (P ¼ 0.003). In contrast, DQUS was not related to AP (P ¼ 0.765).
Concerning nutritional factors influencing bone quality, we found a significant inverse correlation of QUS with calcium, phosphate and vitamin D supply during the week preceding the measurement (P each <0.001). Among further risk factors for 
Multivariate analysis
Linear regression analysis of QUS allowing to correct for postconceptional age, weight at the time of examination, AP and supply with calcium, phosphate, and vitamin D showed all parameters except AP (P ¼ 0.90) and the supply of vitamin D (P ¼ 0.96) as significant independent prognostic factors for bone quality measured by QUS with 20 mm probe distance (Table 5 ). For 35 mm probe distance, in contrast, only postconceptional age could be confirmed as prognostic factor for QUS (P ¼ 0.007).
Discussion
Osteopenia of prematurity develops particularly in very-low-birthweight infants, manifesting as reduced bone mineralization or skull deformity and even fracture. A sufficient postnatal supply of calcium, phosphate and vitamin D is an important prerequisite in the prevention of this illness. 18 However, an optimal supplementation is difficult due to problems with oral feeding and a reduced solubility of calcium and phosphate in nutrition. Unfortunately, a diagnostic method to exactly adjust supplementation to the individual requirement of each neonate is still missing, as is any direct marker to monitor the consequences of low supply: reduced bone quality. QUS is an established osteodensitometric technique in the diagnosis of postmenopausal osteoporosis and a good predictor of fracture risk. 8, 19 This radiation-free technique not only provides information on bone mineral content but also on the micro-architecture of bone, like porosity, trabecular orientation, linkage and elasticity, which are all crucial for the mechanical strength of bone. 5, 7 In our study, measurements on 114 term and preterm infants within their first week of life, representing bone mineralization as close as possible to the intrauterine situation and least altered by postnatal influence of nutrition or illness, showed a highly significant correlation of QUS with gestational age and birth weight. During examination, the children did not show signs of distress, for example, crying or other signs of discomfort. For postnatal bone mineralization, our measurements on 172 neonates showed a correlation of QUS with postconceptional age and the weight on the day of measurement. These values are comparable to those reported from children aged 1 to 6 years (1567 to 1832 m s À1 ) whereas higher values are found in adults (1952 to 2297 m s À1 ). 20 Additionally, QUS increased in particular between 24 and 40 weeks of gestational age and levelled off thereafter. This corresponds both to biochemical analyses of fetal bone and to studies on absorption and retention of nutritional minerals in the fetal skeleton during the last trimenon of pregnancy. 21, 22 These studies have shown an exponential increase of bone mineral density and mechanical breaking strength with gestational age with a maximal bone mineralization rate at 36 weeks of pregnancy followed by a decrease of transplacental supply of the fetus with calcium and phosphate. Our data also confirm previous studies that reported a correlation of bone quality with gestational age and birth weight both by DXA [23] [24] [25] [26] and QUS. [9] [10] [11] [12] [13] [14] [15] 27, 28 Multivariate analysis confirmed postconceptional age as the most relevant predictor of bone quality. Body weight was the strongest predictor of QUS in the most immature infants but lost its significance in term neonates. These results are consistent with data published for X-ray absorptiometry and QUS in older children. 23,25,29 -33 However, postnatal bone mineralization in neonates is discussed controversially. Gonnelli et al.
13 monitored longitudinal changes of bone quality in 73 term infants at birth and 12 months of age. Corresponding to our data, the authors reported a significant increase of QUS with age, when QUS was adjusted for soft tissue thickness by a calculation model. In contrast, in recent studies QUS correlated directly with gestational age and birth weight, whereas the authors found a significant, but inverse correlation of QUS with postnatal age. 9, 15, 34, 35 This was attributed to mineral deficiency and lack of mechanical stimulation, compared with the intrauterine situation. Yet, the follow-up in our study exceeds previously published data, as our patients were followed closely at predefined intervals for up to 4 months after birth and in greater intervals until the age of 17 months. These data revealed an initial decline of QUS during the first weeks of life, which might reflect the negative correlation in other studies. The duration of this decline correlated with the maturity of the neonates, with a more prolonged decrease in the most premature infants. Subsequently, however, QUS increased continuously until reaching a plateau at a postconceptional age of 40 weeks or a body weight of about 3500 g. Although a recent report on 150 preterm infants, where longitudinal data were collected until 14 months of age, also showed an initial QUS decrease, with the lowest nadir and slowest recovery in the most immature infants, the authors attributed this phenomenon to changes in body mass index. 10 However, we observed an identical phenomenon using a measurement technique that accounts for changes of body mass index and reflects bone quality at four different sites. Therefore, this effect might be rather related to maturity and reduced bone mineralization rate in very preterm infants.
Tomlinson et al. 15 published data on serial QUS measurements in 18 preterm infants from birth until 37 weeks of age and found a significant but inverse correlation of QUS and postnatal age. Measurements made early in the postnatal period could not predict bone quality at term in this study. Although the authors attributed this observation to impaired bone strength, their technique did not correct for soft tissue changes, which also would result in a decrease of QUS values. Although we also found a decline in QUS during the first weeks of life, initial bone quality development in the first 3 weeks could predict QUS at term. Additionally, preterm infants at term showed significantly reduced QUS compared with neonates born at term. As in preterm infants the early postnatal period seems to be essential for bone development; prolonged parenteral supplementation might be beneficial.
In SGA infants, growth retardation is in many cases caused by a generalized malnutrition due to placenta insufficiency. 36 A possible mechanism for lower age-dependent QUS values of SGA compared with AGA infants in our study could be a calcium and phosphate deficiency due to reduced placental transfer leading to diminished bone mineralization. As this nutritional restriction does affect growth, length and weight, as well as bone mineralization, this difference could not be detected, when QUS was analyzed in relation to body weight. These findings confirm published data reporting a reduced bone mineral density in SGA compared with AGA infants measured by X-ray absorptiometry and DXA. 37, 38 Two studies using tibial speed of sound reported higher QUS values for SGA compared with AGA infants, which might, however, be explained by a soft-tissue effect that none of the working groups corrected for. 16 ,17 The main cause of osteopenia of prematurity is the postnatally reduced supply of calcium, phosphate and vitamin D. Several studies provide evidence that an increased supply of these substances can improve bone mineral density during the neonatal period as measured by photonabsorption densitometry. 18 In contrast, our data show a significant, but inverse correlation of QUS with the supply of calcium, phosphate and vitamin D. This correlation in our study population can most likely be attributed to the coincidence of an intentionally increased supplementation in extremely preterm infants with low bone density, whereas term infants with comparatively high bone density received less calcium and phosphate per body weight. Although there was no standard supplementation, nutrition was adjusted according to laboratory values. Furthermore, the discrepancy to so far published data might be due to the method of bone quality measurement, as most available studies are based on radiological techniques measuring bone mineral density. In contrast, QUS is also influenced by mechanical and structural properties of bone, which goes beyond sole bone mineral density. 5, 7 Increase in QUS might therefore not be exclusively explained by mineral supply and bone mineral content, but also reflect growing bones with relatively diminished mineralization, which should display as reduced bone-mineral density when using radiological techniques.
One of the parameters used to diagnose osteopenia of prematurity are urinary excretion of calcium and phosphate as well as AP. Although AP is not an established marker for bone turnover, the usefulness of urinary calcium and phosphate excretion is limited due to many confounders influencing the regulation of renal mineral excretion especially in preterm neonates with possibly impaired organ and enzyme function and under treatment of a variety of different medications. 39 Although urinary excretion of calcium and phosphate were not related to QUS in our study, AP correlated inversely with QUS, which confirms reports applying both QUS and DXA that found AP to predict reduced bone density with a sensitivity of 88% and a specificity of 71%. 14, 15, 40, 41 The lack of correlation between AP or QUS and serum levels of calcium or phosphate in our patients is most likely due to the stringent regulation of these two minerals by a complex endocrine system to keep their serum levelFessential for many organ functionsFwithin normal limits. As expected, several risk factors for reduced bone formation showed a relevant influence on QUS, that is, the duration of parenteral nutrition or mechanical ventilation and the treatment with diuretics or corticosteroids. 42 Though we found a strong correlation of QUS with age and weight of the neonates, inter-patient variability was high. Additionally, a s.d. of 15 m s À1 for all measurements contrasted a mean alteration of QUS values by 34 m s À1 per month. Therefore, we did not find it appropriate to define age-and weight-related normal values for our study population. Weight and lengthdependent reference values for intrauterine growth have been published by Ritschl et al 10 , based on QUS measurements of 132 preterm and term infants. In this study, however, a QUS increase of only 12 m s À1 during a weight gain from 500 to 5000 g was contrasted by a mean s.d. of 22 m s À1 per 500 g and limits the use these reference values for the assessment of bone development in clinical practice. In contrast, day-to-day reproducibility in our study was excellent, follow-up measurements of individual patients correlated well with changes in mineral supply, and, above all, bone quality at term could be predicted by QUS development within the first 3 weeks of life. This underlines the clinical relevance of QUS for the monitoring of individual patients and might allow randomized controlled studies to evaluate interventions to treat osteopenia of prematurity.
In conclusion, this study finds QUS to be a highly reproducible, easily applicable and radiation-free technique for the assessment of bone quality in term and preterm infants. Though high intraindividual variation does not permit defining normal values, QUS seems to be a valuable tool to assess bone quality when repeated measurements in individual patients are used. For monitoring of mineral needs, it might be more useful than the determination of calcium and phosphate excretion in urine, which is dependent on medication like diuretics often used in critically ill newborns. In addition, QUS delivers information not only on bone mineralization but also on bone quality and structure that are not covered by mineral excretion. Therefore, its use especially in infants with very low gestational age should allow early detection of osteopenia better than currently available methods. Further prospective randomized studies are necessary to evaluate, if therapeutic interventions based on decreased bone quality measured by QUS are able to reduce the incidence of osteopenia of prematurity.
